Atherosclerosis

Article	Citations
Endothelial dysfunction in COVID-19: Current findings and therapeutic implications	199
Calcium deposition within coronary atherosclerotic lesion: Implications for plaque stability	94
Platelet-leukocyte interplay during vascular disease	91
Systemic immune-inflammation index and incident cardiovascular diseases among middle-aged and elderly Chinese adults: The Dongfeng-Tongji cohort study	83
Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force	79
A link between inflammation and thrombosis in atherosclerotic cardiovascular diseases: Clinical and therapeutic implications	77
Lipoprotein(a) beyond the kringle IV repeat polymorphism: The complexity of genetic variation in the LPA gene	69
Targeting HDAC6 attenuates nicotine-induced macrophage pyroptosis via NF-κB/NLRP3 pathway	67
EPA and DHA differentially modulate monocyte inflammatory response in subjects with chronic inflammation in part via plasma specialized pro-resolving lipid mediators: A randomized, double-blind, cross	64
Trends in lipid-modifying agent use in 83 countries	63
APOE gene variants in primary dyslipidemia	62
High density lipoprotein functionality and cardiovascular events and mortality: A systematic review and meta-analysis	62
Lipoprotein(a) and cardiovascular and valvular diseases: A genetic epidemiological perspective	57
Epicardial fat and coronary artery disease: Role of cardiac imaging	56
The dedicated “Lp(a) clinic”: A concept whose time has arrived?	54
Lipoprotein(a) measurement issues: Are we making a mountain out of a molehill?	50
Managing hyperlipidaemia in patients with COVID-19 and during its pandemic: An expert panel position statement from HEART UK	50
Tissue factor in atherosclerosis and atherothrombosis	50
Carotid intima-media thickness should not be referred to as subclinical atherosclerosis: A recommended update to the editorial policy at Atherosclerosis	49
Platelets as therapeutic targets to prevent atherosclerosis	48
Transendothelial transport of lipoproteins	46
The accuracy of toe brachial index and ankle brachial index in the diagnosis of lower limb peripheral arterial disease: A systematic review and meta-analysis	46
Combination of bempedoic acid, ezetimibe, and atorvastatin in patients with hypercholesterolemia: A randomized clinical trial	45
Shift work, and particularly permanent night shifts, promote dyslipidaemia: A systematic review and meta-analysis	44
Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors	44

Lipoprotein(a) levels from childhood to adulthood: Data in nearly 3,000 children who visited a pediatric lipid clinic	42
HDAC3 protects against atherosclerosis through inhibition of inflammation via the microRNA-19b/PPARγ/NF-κB axis	42
Non-genetic influences on lipoprotein(a) concentrations	42
Innate and adaptive immunity in cardiovascular calcification	41
Existing and emerging strategies to lower Lipoprotein(a)	41
South Asian ethnicity as a risk factor for coronary heart disease	40
TRPA1 regulates macrophages phenotype plasticity and atherosclerosis progression	39
Circulating ceramides as biomarkers of cardiovascular disease: Evidence from phenotypic and genomic studies	39
Prognostic value of coronary artery calcium score, area, and density among individuals on statin therapy vs. non-users: The coronary artery calcium consortium	38
Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: Many happy returns on investment?	37
Cardiac outcomes in patients with acute coronary syndrome attributable to calcified nodule	36
The impact of helical flow on coronary atherosclerotic plaque development	36
atherosclerosis: gone with the Wnt?	36
Marked plaque regression in homozygous familial hypercholesterolemia	36
Brain-heart connections in stress and cardiovascular disease: Implications for the cardiac patient	35
Lipoprotein(a): An underestimated inflammatory mastermind	35
Multifaceted role of extracellular vesicles in atherosclerosis	35
Machine learning integration of circulating and imaging biomarkers for explainable patient-specific prediction of cardiac events: A prospective study	35
New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention?	35
Statin use and mortality in COVID-19 patients: Updated systematic review and meta-analysis	34
Enhanced single-cell RNA-seq workflow reveals coronary artery disease cellular cross-talk and candidate drug targets	34
Cardiovascular events and the role of accelerated atherosclerosis in systemic vasculitis	33
Electronic cigarettes containing nicotine increase endothelial and platelet derived extracellular vesicles in healthy volunteers	33
Oxidized phospholipid modification of lipoprotein(a): Epidemiology, biochemistry and pathophysiology	33
Pre-clinical assessment of SLN360, a novel siRNA targeting LPA, developed to address elevated lipoprotein (a) in cardiovascular disease	33
Sex differences of lipoprotein(a) levels and associated risk of morbidity and mortality by age: The Copenhagen General Population Study	33
Coronavirus disease-19: The multi-level, multi-faceted vasculopathy	32
Lipoprotein (a) and diabetes mellitus	32
The multifaceted impact of complement on atherosclerosis	32
Beyond fibrinolysis: The confounding role of Lp(a) in thrombosis	32
The position of functional foods and supplements with a serum LDL-C lowering effect in the spectrum ranging from universal to care-related CVD risk management	31
Lipoprotein(a) and ethnicities	31
Coronary provocative tests in the catheterization laboratory: Pathophysiological bases, methodological considerations and clinical implications	30
SAFEHEART risk-equation and cholesterol-year-score are powerful predictors of cardiovascular events in French patients with familial hypercholesterolemia	29
Physical activity and exercise improve retinal microvascular health as a biomarker of cardiovascular risk: A systematic review	29
Association of body weight gain with subsequent cardiovascular event in non-obese general population without overt cardiovascular disease	29
Innate and adaptive immune cell subsets as risk factors for coronary heart disease in two population-based cohorts	29
Irisin alleviates vascular calcification by inhibiting VSMC osteoblastic transformation and mitochondria dysfunction via AMPK/Drp1 signaling pathway in chronic kidney disease	29
Association of NPAC score with survival after acute myocardial infarction	28
Fetal toxicity associated with statins: A systematic review and meta-analysis	28
A randomized study investigating the safety, tolerability, and pharmacokinetics of evinacumab, an ANGPTL3 inhibitor, in healthy Japanese and Caucasian subjects	28
Lipid-lowering therapy use in primary and secondary care in Central and Eastern Europe: DA VINCI observational study	28
Sex-specific predictors of PCSK9 levels in a European population: The IMPROVE study	28
Association of blood lipid profile with incident chronic kidney disease: A Mendelian randomization study	27
Risk of myocardial infarction based on endothelial shear stress analysis using coronary angiography	27
Alirocumab treatment and neurocognitive function according to the CANTAB scale in patients at increased cardiovascular risk: A prospective, randomized, placebo-controlled study	27
Prognostic impact of healed coronary plaque in non-culprit lesions assessed by optical coherence tomography	27
Lipoprotein(a), venous thromboembolism and COVID-19: A pilot study	27
Impact of SARS-CoV-2 positivity on clinical outcome among STEMI patients undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registry	27
Recent advances in demystifying the metabolism of lipoprotein(a)	27

Effects of resistance training on endothelial function: A systematic review and meta-analysis	26
Targeting the chemokine network in atherosclerosis	26
Association of beta-2-microglobulin and cardiovascular events and mortality: A systematic review and meta-analysis	26
Impact of clinical and subclinical coronary artery disease as assessed by coronary artery calcium in COVID-19	26
Is protein the forgotten ingredient: Effects of higher compared to lower protein diets on cardiometabolic risk factors. A systematic review and meta-analysis of randomised controlled trials	26
Additive contribution of microRNA-34a/b/c to human arterial ageing and atherosclerosis	25
Familial hypercholesterolaemia and COVID-19: A two-hit scenario for endothelial dysfunction amenable to treatment	25
Omega-3 fatty acids ameliorate vascular inflammation: A rationale for their atheroprotective effects	25
Blood urea nitrogen, blood urea nitrogen to creatinine ratio and incident stroke: The Dongfeng-Tongji cohort	25
Colchicine reduces extracellular vesicle NLRP3 inflammasome protein levels in chronic coronary disease: A LoDoCo2 biomarker substudy	25
Phenylacetylglutamine is associated with the degree of coronary atherosclerotic severity assessed by coronary computed tomographic angiography in patients with suspected coronary artery disease	24
International Union of Angiology (IUA) consensus paper on imaging strategies in atherosclerotic carotid artery imaging: From basic strategies to advanced approaches	24
The multifaceted contribution of platelets in the emergence and aftermath of acute cardiovascular events	24
The relation between healthy lifestyle changes and decrease in systemic inflammation in patients with stable cardiovascular disease	24
Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features	24
Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society	24
Associations between particulate matter air pollution, presence and progression of subclinical coronary and carotid atherosclerosis: A systematic review	24
Vascular imaging of atherosclerosis: Strengths and weaknesses	24
Natural compounds as anti-atherogenic agents: Clinical evidence for improved cardiovascular outcomes	24
Fasting plasma glucose and subsequent cardiovascular disease among young adults: Analysis of a nationwide epidemiological database	23
Loss of statin treatment years during pregnancy and breastfeeding periods in women with familial hypercholesterolemia	23
The relationship between cardiorespiratory fitness, cardiovascular risk factors and atherosclerosis	23
The emerging landscape of peptide-based inhibitors of PCSK9	23
A systematic review and meta-analysis on the effects of statins on pregnancy outcomes	23
Lipoprotein(a) levels and atherosclerotic plaque characteristics in the carotid artery: The Plaque at RISK (PARISK) study	23
Photon-counting CT with tungsten as contrast medium: Experimental evidence of vessel lumen and plaque visualization	23
Blocking the NLRP3 inflammasome reduces osteogenic calcification and M1 macrophage polarization in a mouse model of calcified aortic valve stenosis	22
Role of mechanical stress and neutrophils in the pathogenesis of plaque erosion	22
Lipid levels, atrial fibrillation and the impact of age: Results from the LIPIDOGRAM2015 study	22
Intravascular ultrasound-based deep learning for plaque characterization in coronary artery disease	22
Is periodontitis a risk factor for ischaemic stroke, coronary artery disease and subclinical atherosclerosis? A Mendelian randomization study	22
New insights into endogenous mechanisms of protection against arterial calcification	22
Predictors of coronary artery calcium among 20-30-year-olds: The Coronary Artery Calcium Consortium	22
Mitochondria-targeted esculetin mitigates atherosclerosis in the setting of aging via the modulation of SIRT1-mediated vascular cell senescence and mitochondrial function in Apoe mice	21
Exploring the relationship between biomechanical stresses and coronary atherosclerosis	21
Associations between plasma ceramides and mortality in patients with coronary artery disease	21
No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels	21
Platelet “-omics” in health and cardiovascular disease	20
Statin therapy for the primary prevention of cardiovascular disease: Pros	20
Lifestyle intervention using mobile technology and smart devices in patients with high cardiovascular risk: A pragmatic randomised clinical trial	20
Lipid-lowering therapies: Better together	20
Targeting the phenotypic switch of vascular smooth muscle cells to tackle atherosclerosis	20
Role of mitochondrial DNA copy number in incident cardiovascular diseases and the association between cardiovascular disease and type 2 diabetes: A follow-up study on middle-aged women	20
Impact of air pollution on ischemic heart disease: Evidence, mechanisms, clinical perspectives	20
Prevalence and influence of LPA gene variants and isoform size on the Lp(a)-lowering effect of pelacarsen	20
Inferior control of low-density lipoprotein cholesterol in women is the primary sex difference in modifiable cardiovascular risk: A large-scale, cross-sectional study in primary care	20
Cumulative dyslipidemia with arterial stiffness and carotid IMT progression in asymptomatic adolescents: A simulated intervention longitudinal study using temporal inverse allocation model	20
Sex differences in impact of long-term burden and trends of body mass index and blood pressure from childhood to adulthood on arterial stiffness in adults: A 30-year cohort study	20
Cardiovascular effects of omega-3 fatty acids: Hope or hype?	19
Macrophage infiltrates in coronary plaque erosion and cardiovascular outcome in patients with acute coronary syndrome	19
Angiopoietin-like protein 8 accelerates atherosclerosis in ApoE−/− mice	19
Actin remodelling of the endothelium during transendothelial migration of leukocytes	19
Extracellular vesicles in atherothrombosis and cardiovascular disease: Friends and foes	19
Preclinical atherosclerosis and cardiovascular events: Do we have a consensus about the role of preclinical atherosclerosis in the prediction of cardiovascular events?	19
Macrophage polarisation associated with atherosclerosis differentially affects their capacity to handle lipids	19
Elevated lipoprotein(a) in mitral and aortic valve calcification and disease: The Copenhagen General Population Study	19
Sex differences in cardiovascular morbidity associated with familial hypercholesterolaemia: A retrospective cohort study of the UK Simon Broome register linked to national hospital records	19
IMT is not atherosclerosis	19
The long journey of lipoprotein(a) from cardiovascular curiosity to therapeutic target	19
Role of RhoA and Rho-associated kinase in phenotypic switching of vascular smooth muscle cells: Implications for vascular function	19
Hyperlipidemia does not affect development of elastase-induced abdominal aortic aneurysm in mice	19
Coronary artery calcium scores indicating secondary prevention level risk: Findings from the CAC consortium and FOURIER trial	19
Polygenic risk score and coronary artery disease: A meta-analysis of 979,286 participant data	19
Heightened splenic and bone marrow uptake of 18F-FDG PET/CT is associated with systemic inflammation and subclinical atherosclerosis by CCTA in psoriasis: An observational study	19
DA VINCI study: Change in approach to cholesterol management will be needed to reduce the implementation gap between guidelines and clinical practice in Europe	19
The difference between cystatin C- and creatinine-based eGFR is associated with adverse cardiovascular outcome in patients with chronic kidney disease	18
Human apolipoprotein A-II reduces atherosclerosis in knock-in rabbits	18
How strong is the evidence that gut microbiota composition can be influenced by lifestyle interventions in a cardio-protective way?	18
Does variation in serum LDL-cholesterol response to dietary fatty acids help explain the controversy over fat quality and cardiovascular disease risk?	18
Association of plasma trimethylamine N-oxide levels with atherosclerotic cardiovascular disease and factors of the metabolic syndrome	18
A meta-analysis of medications directed against PCSK9 in familial hypercholesterolemia	18
Chronic kidney disease measures for cardiovascular risk prediction	18
Exploring the causal pathway from bilirubin to CVD and diabetes in the UK biobank cohort study: Observational findings and Mendelian randomization studies	18
Wall shear stress estimated by 3D-QCA can predict cardiovascular events in lesions with borderline negative fractional flow reserve	18
Effects of proprotein convertase subtilisin kexin type 9 modulation in human pancreatic beta cells function	18
Single cell analyses to understand the immune continuum in atherosclerosis	18
Baseline or 90-day fibrinogen levels and long-term outcomes after ischemic stroke or TIA: Results from the China national stroke registry Ⅲ	17
Lipoprotein (a) and aortic valve calcium in South Asians compared to other race/ethnic groups	17
Semaglutide reduces vascular inflammation investigated by PET in a rabbit model of advanced atherosclerosis	17
MDM2 contributes to oxidized low-density lipoprotein-induced inflammation through modulation of mitochondrial damage in endothelial cells	17

Comparison of the mutation spectrum and association with pre and post treatment lipid measures of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries	17
Low muscle mass is associated with carotid atherosclerosis in patients with type 2 diabetes	17
Polyvascular disease: A narrative review of current evidence and a consideration of the role of antithrombotic therapy	17
The association of serum lipid and lipoprotein levels with total and differential leukocyte counts: Results of a cross-sectional and longitudinal analysis of the UK Biobank	17
The effect of transgender hormonal treatment on high density lipoprotein cholesterol efflux capacity	17
Aortic valve calcification predicts all-cause mortality independent of coronary calcification and severe stenosis	17
Serum lipoprotein(a) levels and insulin resistance have opposite effects on fatty liver disease	17
Long-term persistence with evolocumab treatment and sustained reductions in LDL-cholesterol levels over 30 months: Final results from the European observational HEYMANS study	17
Is estimated cardiorespiratory fitness an effective predictor for cardiovascular and all-cause mortality? A meta-analysis	16
Hyperinsulinemia promotes endothelial inflammation via increased expression and release of Angiopoietin-2	16
Genotype-phenotype correlation in pseudoxanthoma elasticum	16
Coronary plaque burden, plaque characterization and their prognostic implications in familial hypercholesterolemia: A computed tomographic angiography study	16
Mendelian Randomization: Principles and its usage in Lp(a) research	16
A phase 2 trial of the efficacy and safety of evinacumab in patients with severe hypertriglyceridemia	16
Genetics of adrenergic signaling drives coronary artery calcification	16
Characteristics of atherosclerosis in femoropopliteal artery and its clinical relevance	16
Added value of high-risk plaque criteria by coronary CTA for prediction of long-term outcomes	16
Long noncoding RNA ZNF800 suppresses proliferation and migration of vascular smooth muscle cells by upregulating PTEN and inhibiting AKT/mTOR/HIF-1α signaling	16
Estimation of the major cardiovascular events prevention with Inclisiran	16
Risk-factors associated with extremely high cardiovascular risk of mid- and long-term mortality following myocardial infarction: Analysis of the Hyperlipidaemia Therapy in tERtiary Cardiological cEnTe	16
Molecular genetic testing for autosomal dominant hypercholesterolemia in 29,449 Norwegian index patients and 14,230 relatives during the years 1993–2020	16
2.5-fold increased risk of recurrent acute myocardial infarction with familial hypercholesterolemia	16
Hypoxia inducible factor 1α inhibitor PX-478 reduces atherosclerosis in mice	16
Mid-term predictive value of calciprotein particles in maintenance hemodialysis patients based on a gel-filtration assay	16
Ischemia and no obstructive coronary arteries (INOCA): A narrative review	16
Visit-to-visit variability of lipid measurements and the risk of myocardial infarction and all-cause mortality: A prospective cohort study	15
The association between plasma proteomics and incident cardiovascular disease identifies MMP-12 as a promising cardiovascular risk marker in patients with chronic kidney disease	15
Endothelial cells exposed to atheroprotective flow secrete follistatin-like 1 protein which reduces transcytosis and inflammation	15
Acute ischemic stroke versus transient ischemic attack: Differential plaque morphological features in symptomatic intracranial atherosclerotic lesions	15
Age- and sex-specific trends in the incidence of myocardial infarction in Denmark, 2005 to 2021	15
Carotid plaque is strongly associated with coronary artery calcium and predicts incident coronary heart disease in a population-based cohort	15
Should we target increased physical activity or less sedentary behavior in the battle against cardiovascular disease risk development?	15
The gut microbiota is associated with clinical response to statin treatment in patients with coronary artery disease	15
Hyperuricemia precedes non-alcoholic fatty liver disease with abdominal obesity moderating this unidirectional relationship: Three longitudinal analyses	15
Regression in carotid plaque lipid content and neovasculature with PCSK9 inhibition: A time course study	15
Association of circulating branched-chain amino acids with risk of cardiovascular disease: A systematic review and meta-analysis	15
Possible association between eating behaviors and cardiovascular disease in the general population: Analysis of a nationwide epidemiological database	15
Spousal similarities in cardiometabolic risk factors: A cross-sectional comparison between Dutch and Japanese data from two large biobank studies	15
The important role of histone deacetylases in modulating vascular physiology and arteriosclerosis	15
Carotid intima-media thickness and subclinical left heart dysfunction in the general population	15
Sex related differences in therapy and outcome of patients with intermittent claudication in a real-world cohort	15
Transcriptome analysis revealed a two-step transformation of vascular smooth muscle cells to macrophage-like cells	14
Dietary sucrose induces metabolic inflammation and atherosclerotic cardiovascular diseases more than dietary fat in LDLr ApoB100/100 mice	14
Smoking and sex differences in first manifestation of cardiovascular disease	14
Predictors of coronary artery calcium incidence and progression: The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)	14
Relationship between elevated plasma ceramides and plaque rupture in patients with ST-segment elevation myocardial infarction	14
The LDL-C/ApoB ratio predicts major cardiovascular events in patients with established atherosclerotic cardiovascular disease	14
Progression of valvular calcification and risk of incident stroke: The Multi-Ethnic Study of Atherosclerosis (MESA)	14
Prognostic significance of subtle coronary calcification in patients with zero coronary artery calcium score: From the CONFIRM registry	14
Heterogeneity of non-alcoholic fatty liver disease (NAFLD): Implication for cardiovascular risk stratification	14
The regulation of Ero1-alpha in homocysteine-induced macrophage apoptosis and vulnerable plaque formation in atherosclerosis	14
Cholesterol crystals drive metabolic reprogramming and M1 macrophage polarisation in primary human macrophages	14
High lipoprotein(a) is associated with major adverse limb events after femoral artery endarterectomy	14
Endothelial glycocalyx and severity and vulnerability of coronary plaque in patients with coronary artery disease	14
The age- and sex-specific composition of atherosclerotic plaques in vascular surgery patients	14
Lipoprotein(a) in hereditary hypercholesterolemia: Influence of the genetic cause, defective gene and type of mutation	14
Association between serum glycated albumin and risk of cardiovascular disease in a Japanese community: The Hisayama Study	14
PCSK9 promotes arterial medial calcification	14
The NO-donor MPC-1011 stimulates angiogenesis and arteriogenesis and improves hindlimb ischemia via a cGMP-dependent pathway involving VEGF and SDF-1α	14
Elevated levels of serum PCSK9 in male patients with symptomatic peripheral artery disease: The CAVASIC study	14
Trends and consequences of lipoprotein(a) testing: Cross-sectional and longitudinal health insurance claims database analyses	14
Sex differences in lipids: A life course approach	13
Coronary 18F-sodium fluoride PET detects high-risk plaque features on optical coherence tomography and CT-angiography in patients with acute coronary syndrome	13
Association of remnant cholesterol with risk of cardiovascular disease events, stroke, and mortality: A systemic review and meta-analysis	13
Abdominal aortic calcification is associated with a higher risk of injurious fall-related hospitalizations in older Australian women	13
Regulation of intestinal LDLR by the LXR-IDOL axis	13
Low shear stress inhibits endothelial mitophagy via caveolin-1/miR-7-5p/SQSTM1 signaling pathway	13
A novel GPIHBP1 mutation related to familial chylomicronemia syndrome: A series of cases	13
Apolipoprotein M and its impact on endothelial dysfunction and inflammation in the cardiovascular system	13
The C57Bl/6J mouse strain is more susceptible to angiotensin II-induced aortic aneurysm formation than C57Bl/6N	13
Saline-induced coronary hyperemia with continuous intracoronary thermodilution is mediated by intravascular hemolysis	13
Association of plaque calcification pattern and attenuation with instability features and coronary stenosis and calcification grade	13
Apolipoprotein E genotype, lifestyle and coronary artery disease: Gene-environment interaction analyses in the UK Biobank population	13
Macrophage metabolic regulation in atherosclerotic plaque	13
Risk of peripheral artery disease according to race and sex: The Atherosclerosis Risk in Communities (ARIC) study	13
An elevated ankle-brachial index is not a valid proxy for peripheral medial arterial calcification	13
Periodontal treatment and vascular inflammation in patients with advanced peripheral arterial disease: A randomized controlled trial	13
ApoB48-remnant lipoproteins are associated with increased cardiometabolic risk in adolescents	13
Family history and polygenic risk of cardiovascular disease: Independent factors associated with secondary cardiovascular events in patients undergoing carotid endarterectomy	13
Debris collected in-situ from spontaneously ruptured atherosclerotic plaque invariably contains large cholesterol crystals and evidence of activation of innate inflammation: Insights from non-obstruct	13
Lomitapide for treatment of homozygous familial hypercholesterolemia: The Québec experience	13
Weight change during middle age and risk of stroke and coronary heart disease: The Japan Public Health Center–based Prospective Study	13
High levels of eicosapentaenoic acid are associated with lower pericoronary adipose tissue attenuation as measured by coronary CTA	13
Methodological issues regarding: “A third of nonfasting plasma cholesterol is in remnant lipoproteins: Lipoprotein subclass profiling in 9293 individuals”	13
Lipolytic enzymes and free fatty acids at the endothelial interface	13
Low-density lipoprotein aggregation predicts adverse cardiovascular events in peripheral artery disease	13
Quantitative evaluation of statin effectiveness versus intolerance and strategies for management of intolerance	13
Carotid stent occlusion after emergent stenting in acute ischemic stroke: Incidence, predictors and clinical relevance	13
Relationship of low-density lipoprotein-cholesterol and lipoprotein(a) to cardiovascular risk: The Multi-Ethnic Study of Atherosclerosis (MESA)	13
CREB/ATF3 signaling mediates indoxyl sulfate-induced vascular smooth muscle cell proliferation and neointimal formation in uremia	13
Complementary roles of platelet αIIbβ3 integrin, phosphatidylserine exposure and cytoskeletal rearrangement in the release of extracellular vesicles	13
Pulse wave velocity, augmentation index, and carotid intima-media thickness are each associated with different inflammatory protein signatures in young healthy adults: The lifestyle, biomarkers and at	12
Lifetime risk predictions for cardiovascular diseases: Competing risks analyses on a population-based cohort in Sweden	12
Polygenic architecture and cardiovascular risk of familial combined hyperlipidemia	12
Bone mineral density and long-term progression of aortic valve and mitral annular calcification: The Multi-Ethnic Study of Atherosclerosis	12